TP53 and lung carcinoma: Two different but effective delivery strategies, the PAM-Ap/pMiR-34a and the Coated Cationic Lipid-nanoparticles entrapping miR-660 (CCL660) have been found to contribute in inhibition of lung cancer cell proliferation, migration, invasion and promoting apoptosis by restoring the activity of p53 [243,244].